Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2020 Aug:158:104896.
doi: 10.1016/j.phrs.2020.104896. Epub 2020 May 11.

Efficacy and Safety of Integrated Traditional Chinese and Western Medicine for Corona Virus Disease 2019 (COVID-19): a systematic review and meta-analysis

Ming Liu  1 , Ya Gao  1 , Yuan Yuan  2 , Kelu Yang  3 , Shuzhen Shi  1 , Junhua Zhang  4 , Jinhui Tian  5
Affiliations
Meta-Analysis

Efficacy and Safety of Integrated Traditional Chinese and Western Medicine for Corona Virus Disease 2019 (COVID-19): a systematic review and meta-analysis

Ming Liu et al. Pharmacol Res. 2020 Aug.

Abstract

Corona virus disease (COVID-19) has now spread to all parts of the world and almost all countries are battling against it. This study aimed to assess the efficacy and safety of Integrated Traditional Chinese and Western Medicine (Hereinafter referred to as "Integrated Medicine") to COVID-19. We searched six major Chinese and English databases to identify randomized controlled trials (RCTs) and case-control studies (CCSs) of Integrated Medicine on COVID-19. Two reviewers independently screened, identified studies, and extracted data. Cochrane Risk of Bias tool and the Newcastle-Ottawa Scale were used to assess the quality of included RCTs and CCSs, respectively. Stata (version 13.0; StataCorp) was used to perform meta-analyses with the random-effects model. Risk ratio (RR) was used for dichotomous data while the weighted mean difference (WMD) was adopted for continuous variables as effect size, both of which were demonstrated in effect size and 95% confidence intervals (CI). A total of 11 studies were included. Four were RCTs and seven were CCSs. The sample size of including studies ranged from 42 to 200 (total 982). The traditional Chinese medicine included Chinese medicine compound drugs (QingFei TouXie FuZhengFang) and Chinese patent medicine (e.g. Shufeng Jiedu Capsule, Lianhua Qingwen granules). Compared with the control group, the overall response rate [RR = 1.230, 95%CI (1.113, 1.359), P = 0.000], cure rate [RR = 1.604, 95%CI (1.181, 2.177), P = 0.002], severity illness rate [RR = 0.350, 95%CI (0.154, 0.792), P = 0.012], and hospital stay [WMD = -1.991, 95%CI (-3.278, -0.703), P = 0.002] of the intervention group were better. In addition, Integrated Medicine can improve the disappearance rate of fever, cough, expectoration, fatigue, chest tightness and anorexia and reduce patients' fever, and fatigue time (P < 0.05). This review found that Integrated Medicine had better effects and did not increase adverse drug reactions for COVID-19. More high-quality RCTs are needed in the future.

Keywords: COVID-19; Efficacy; Integrated Traditional Chinese and Western Medicine; Meta-analysis; Safety.

PubMed Disclaimer

Figures

None
Graphical abstract
Fig. 1
Fig. 1
Flow Diagram of Literature Search and Trial Selection.
Fig. 2
Fig. 2
Overall response rate of the COVID-19 between Integrated Medicine and Western Medicine.
Fig. 3
Fig. 3
Cure rate of the COVID-19 between Integrated Medicine and Western Medicine.
Fig. 4
Fig. 4
Severity illness rate of the COVID-19 between Integrated Medicine and Western Medicine.
Fig. 5
Fig. 5
Hospital stay of the COVID-19 between Integrated Medicine and Western Medicine.
See this image and copyright information in PMC

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Hui D.S., Azhar E.I., Madani T.A. The continuing 2019- nCoV epidemic threat of novel coronaviruses to global health-the latest 2019 novel coronavirus outbreak in Wuhan, China. Int. J. Infect. Dis. 2020;91:264–266. - PMC - PubMed
    1. W.H.O., Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance. Jan 11, 2020. https://www.who.int/internal-publications-detail/clinical-management-of-... (accessed 24 March 2020).
    1. Nie J.H., Li Q.Q., Wu J.J. Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2. Emerg. Microbes. Infect. 2020;9:680–685. - PMC - PubMed
    1. Coronavirus Outbreak, available at: https://www.worldometers.info/coronavirus/. (accessed 27 March 2020).
    1. General Office of the National Health and Health Commission, Office of the State Administration of Traditional Chinese Medicine. Notice on Issuing a New Coronary Virus Pneumonia Diagnosis and Treatment guidelines (Trial Version 7) [EB/OL], http://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb19..., (accessed 4 March 2020).